Differential Variation Analysis Enables Detection of Tumor Heterogeneity Using Single-Cell RNA-Sequencing Data

被引:23
|
作者
Davis-Marcisak, Emily F. [1 ,2 ]
Sherman, Thomas D. [2 ]
Orugunta, Pranay [2 ]
Stein-O'Brien, Genevieve L. [1 ,2 ,3 ]
Puram, Sidharth V. [4 ,5 ]
Torres, Evanthia T. Roussos [2 ]
Hopkins, Alexander C. [6 ]
Jaffee, Elizabeth M. [2 ]
Favorov, Alexander V. [2 ,7 ]
Afsari, Bahman [2 ]
Goff, Loyal A. [1 ,3 ]
Fertig, Elana J. [2 ,8 ,9 ]
机构
[1] Johns Hopkins Sch Med, Dept Med Genet, McKusick Nathans Inst, Baltimore, MD USA
[2] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD USA
[3] Johns Hopkins Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA
[4] Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, St Louis, MO USA
[5] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA
[6] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA
[7] Russian Acad Sci, Lab Syst Biol & Computat Genet, Vavilov Inst Gen Genet, Moscow, Russia
[8] Johns Hopkins Univ, Dept Appl Math & Stat, Whiting Sch Engn, Baltimore, MD USA
[9] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA
关键词
TRANSCRIPTOMIC ANALYSIS; VARIABILITY; CANCER; GENES; HEAD;
D O I
10.1158/0008-5472.CAN-18-3882
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor heterogeneity provides a complex challenge to cancer treatment and is a critical component of therapeutic response, disease recurrence, and patient survival. Single-cell RNA-sequencing (scRNA-seq) technologies have revealed the prevalence of intratumor and intertumor heterogeneity. Computational techniques are essential to quantify the differences in variation of these profiles between distinct cell types, tumor subtypes, and patients to fully characterize intratumor and intertumor molecular heterogeneity. In this study, we adapted our algorithm for pathway dysregulation, Expression Variation Analysis (EVA), to perform multivariate statistical analyses of differential variation of expression in gene sets for scRNA-seq. EVA has high sensitivity and specificity to detect pathways with true differential heterogeneity in simulated data. EVA was applied to several public domain scRNA-seq tumor datasets to quantify the landscape of tumor heterogeneity in several key applications in cancer genomics such as immunogenicity, metastasis, and cancer subtypes. Immune pathway heterogeneity of hematopoietic cell populations in breast tumors corresponded to the amount of diversity present in the T-cell repertoire of each individual. Cells from head and neck squamous cell carcinoma (HNSCC) primary tumors had significantly more heterogeneity across pathways than cells from metastases, consistent with a model of clonal outgrowth. Moreover, there were dramatic differences in pathway dysregulation across HNSCC basal primary tumors. Within the basal primary tumors, there was increased immune dysregulation in individuals with a high proportion of fibroblasts present in the tumor microenvironment. These results demonstrate the broad utility of EVA to quantify intertumor and intratumor heterogeneity from scRNA-seq data without reliance on low-dimensional visualization. Significance: This study presents a robust statistical algorithm for evaluating gene expression heterogeneity within pathways or gene sets in single-cell RNA-seq data
引用
收藏
页码:5102 / 5112
页数:11
相关论文
共 50 条
  • [41] Single-cell RNA sequencing analysis to explore immune cell heterogeneity and novel biomarkers for the prognosis of lung adenocarcinoma
    Xu, Yong
    Wang, Yao
    Liang, Leilei
    Song, Nan
    FRONTIERS IN GENETICS, 2022, 13
  • [42] Recharacterizing Tumor-Infiltrating Lymphocytes by Single-Cell RNA Sequencing
    Zhang, Lei
    Zhang, Zemin
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (07) : 1040 - 1046
  • [43] Analysis of Single-Cell RNA Sequencing Data Unveils Novel Immune Prognostic Biomarkers
    Zhang, Wenjuan
    Lee, Alex
    Yang, Mary Qu
    2023 INTERNATIONAL CONFERENCE ON COMPUTATIONAL SCIENCE AND COMPUTATIONAL INTELLIGENCE, CSCI 2023, 2023, : 558 - 563
  • [44] Single-cell differential splicing analysis reveals high heterogeneity of liver tumor-infiltrating T cells
    Liu, Shang
    Zhou, Biaofeng
    Wu, Liang
    Sun, Yan
    Chen, Jie
    Liu, Shiping
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [45] A Comprehensive Survey of Statistical Approaches for Differential Expression Analysis in Single-Cell RNA Sequencing Studies
    Das, Samarendra
    Rai, Anil
    Merchant, Michael L.
    Cave, Matthew C.
    Rai, Shesh N.
    GENES, 2021, 12 (12)
  • [46] Autophagy-prominent cell clusters among human lens epithelial cells: integrated single-cell RNA-sequencing analysis
    Liu, Jiasheng
    Zhu, Mengchao
    Xu, Yitong
    Zhang, Mengdi
    Sun, Haisen
    Wang, Yaqi
    Yang, Qingwen
    Li, Jin
    BMC OPHTHALMOLOGY, 2023, 23 (01)
  • [47] Tutorial: integrative computational analysis of bulk RNA-sequencing data to characterize tumor immunity using RIMA
    Yang, Lin
    Wang, Jin
    Altreuter, Jennifer
    Jhaveri, Aashna
    Wong, Cheryl J. J.
    Song, Li
    Fu, Jingxin
    Taing, Len
    Bodapati, Sudheshna
    Sahu, Avinash
    Tokheim, Collin
    Zhang, Yi
    Zeng, Zexian
    Bai, Gali
    Tang, Ming
    Qiu, Xintao
    Long, Henry W. W.
    Michor, Franziska
    Liu, Yang
    Liu, X. Shirley
    NATURE PROTOCOLS, 2023, 18 (08) : 2404 - 2414
  • [48] Aneuploidy: An opportunity within single-cell RNA sequencing analysis
    Delaney, Joe R.
    BIOCELL, 2021, 45 (05) : 1167 - 1170
  • [49] Prognostic model based on B cell marker genes for NSCLC patients under neoadjuvant immunotherapy by integrated analysis of single-cell and bulk RNA-sequencing data
    Liu, Yang
    Bie, Fenglong
    Bai, Guangyu
    Huai, Qilin
    Li, Yuan
    Chen, Xiaowei
    Zhou, Bolun
    Gao, Shugeng
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (08): : 2025 - 2036
  • [50] Single-Cell RNA Sequencing Maps Immune Cell Heterogeneity in Mice with Allogeneic Cardiac Transplantation
    Tong, Zhonghua
    Mang, Ge
    Wang, Dongni
    Cui, Jingxuan
    Yang, Qiannan
    Zhang, Maomao
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2023, 8 (01)